Phase 1 Clinical Trial of DA-5207 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions

Healthy

Interventions

DRUG

Aricept 5mg Tablet

1 tablet once daily

DRUG

Aricept 10mg Tablet

1 tablet once daily

DRUG

DA-5207 A

1 patch once weekly

DRUG

DA-5207 B

1 patch once weekly

Trial Locations (1)

Jeonbuk National University Hospital, Jeonju

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT05127746 - Phase 1 Clinical Trial of DA-5207 in Healthy Adults | Biotech Hunter | Biotech Hunter